Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansion

The Journal of Experimental Medicine(2022)10.1084/jem.20212434Source: DataRank Database

Differential IL-12 signaling induces human natural killer cell activating receptor-mediated ligand-specific expansion is a research paper published in The Journal of Experimental Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 54 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access54 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.00)OA: greenTopics (39)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Harry Pickering ORCID,Kole T. Roybal ORCID,Lewis L. Lanier ORCID,Avishai Shemesh ORCID

Live enrichment

PubMed:35758909 OpenAlex:https://openalex.org/W35758909

National Institutes of Health

Grant: AI068129

National Institutes of Health

Grant: U19AI128913

National Institutes of Health

Grant: 5R01AI068129-15

NK Cell Receptors and their Ligands

National Institutes of Health

Grant: 5U19AI128913-05

Mapping Immune Responses to CMV in Renal Transplant Recipients

NIAID NIH HHS

Grant: R01 AI068129

Irvington Cancer Research Institute

University of California, San Francisco

Parker Institute for Cancer Immunotherapy

FWCI

0.00

Citation Percentile

0.0%

greenLicense: CC BY NC SA

journalhttps://dialnet.unirioja.es/servlet/articulo?codigo=53264

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9240274

publisherhttps://rupress.org/jem/article-pdf/doi/10.1084/jem.20212434/1771990/jem_20212434.pdf

https://doi.org/10.1084/jem.20212434

https://pubmed.ncbi.nlm.nih.gov/35758909

Fields of Study

Regional Development and InnovationRegional Economic and Spatial AnalysisRegional Development and Policy0301 basic medicine03 medical and health sciencesCell ProliferationHumansInterleukin-12Interleukin-2LigandsReceptors, Natural Killer CellSTAT5 Transcription Factor

MeSH Terms

Cell ProliferationHumansInterleukin-12Interleukin-2LigandsReceptors, Natural Killer CellSTAT5 Transcription Factor

Keywords

HumanitiesPolitical scienceGeographyArtImmunologyLigandsMedical and Health SciencesInterleukin-12ArticleVaccine RelatedInfectious DiseasesReceptorsSTAT5 Transcription Factor2.1 Biological and endogenous factorsHumansInterleukin-2Receptors, Natural Killer CellAetiologyNatural Killer CellCell Proliferation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Industry, innovation and infrastructure